The estimated Net Worth of James M Gower is at least $2.34 Million dollars as of 2 November 2005. James Gower owns over 50,000 units of Rigel Pharmaceuticals stock worth over $2,343,368 and over the last 21 years James sold RIGL stock worth over $0.
James has made over 1 trades of the Rigel Pharmaceuticals stock since 2005, according to the Form 4 filled with the SEC. Most recently James exercised 50,000 units of RIGL stock worth $90,000 on 2 November 2005.
The largest trade James's ever made was exercising 50,000 units of Rigel Pharmaceuticals stock on 2 November 2005 worth over $90,000. On average, James trades about 3,125 units every 0 days since 2003. As of 2 November 2005 James still owns at least 180,676 units of Rigel Pharmaceuticals stock.
You can see the complete history of James Gower stock trades at the bottom of the page.
James's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over $170,041,384 worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth $7,281,949 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Ansbert Gadicke, and Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $961,207. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth $16,552.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: